Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Bladder cancer trimodality therapy

Srikala Sridhar, MD, MSc, FRCPC, Princess Margaret Hospital, Toronto, ON, Canada, discusses how recent advances have led to bladder-sparing trimodality therapy (TMT) to become an accepted alternative to cystectomy for selected muscle invasive bladder cancer patients who are unfit for cystectomy. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.